All Stories

  1. Challenges in the Discovery and Optimization of mGlu2/4 Heterodimer Positive Allosteric Modulators

    Article • Letters in Drug Design & Discovery, November 2019, Bentham Science Publishers

    Jeffrey Conn

  2. Differential Pharmacology and Binding of mGlu2 Receptor Allosteric Modulators

    Article • Molecular Pharmacology, March 2018, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Jeffrey Conn

  3. Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation

    Article • Molecular Pharmacology, March 2015, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Jeffrey Conn

  4. Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia

    Article • Neuropsychiatric Disease and Treatment, January 2014, Taylor & Francis

    Jeffrey Conn